Background: Universal mismatch repair immunohistochemistry (MMR IHC) tumour testing in endometrial cancer (EC) for Lynch syndrome (LS) was introduced in Auckland, New Zealand, in January 2017. Identifying patients with LS allows them and their families to access risk reduction strategies. Universal MMR IHC testing aids in the molecular classification of EC and has prognostic and therapeutic implications.
View Article and Find Full Text PDFAim: High and low gestational weight gain (GWG) adversely affects perinatal outcomes, and impacts long-term maternal and child health. Our aim is to report i) GWG categories by 2009 Institute of Medicine guidelines in the multi-ethnic population in Counties Manukau Health, ii) demographic factors and iii) adverse perinatal outcomes associated with high and low GWG.
Method: Women with singleton pregnancy and weight recorded at ≤20 weeks and again in the third trimester comprised the study population.